Patten & Patten Inc Aurinia Pharmaceuticals Inc. Transaction History
Patten & Patten Inc
- $1.43 Billion
- Q4 2024
A detailed history of Patten & Patten Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Patten & Patten Inc holds 75,354 shares of AUPH stock, worth $588,514. This represents 0.05% of its overall portfolio holdings.
Number of Shares
75,354
Previous 92,544
18.57%
Holding current value
$588,514
Previous $678,000
0.29%
% of portfolio
0.05%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding AUPH
# of Institutions
220Shares Held
59.3MCall Options Held
1.17MPut Options Held
1.54M-
Black Rock Inc. New York, NY9.27MShares$72.4 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$64 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$56.5 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$31 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$23 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.11B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...